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Drinking Water and Cancer
Robert D. Morris
Department of Family and Community Medicine, Medical College ofWisconsin, Milwaukee, Wisconsin
Any and all chemicals generated by human activity can and will find their way into water supplies. The types and quantities of carcinogens present in
drinking water at the point of consumption will differ depending on whether they result from contamination of the source water, arise as a
consequence of treatment processes, or enter as the water is conveyed to the user. Source-water contaminants of concern include arsenic,
asbestos, radon, agricultural chemicals, and hazardous waste. Of these, the strongest evidence for a cancer risk involves arsenic, which is linked to
cancers of the liver, lung, bladder, and kidney. The use of chlorine for water treatment to reduce the risk of infectious disease may account for a
substantial portion of the cancer risk associated with drinking water. The by-products of chlorination are associated with increased risk of bladder
and rectal cancer, possibly accounting for 5000 cases of bladder cancer and 8000 cases of rectal cancer per year in the United States. Fluoridation of
water has received great scrutiny but appears to pose little or no cancer risk. Further research is needed to identify and quantify risks posed by
contaminants from drinking-water distribution pipes, linings, joints, and fixtures and by biologically active micropollutants, such as microbial agents.
We need more cost-effective methods for monitoring drinking-water quality and further research on interventions to minimize cancer risks from
drinking water. - Environ Health Perspect 103(Suppl 8):225-232 (1995)
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Introduction
Few things tie humans so directly to the
natural environment as drinking water.
The contamination of water is a direct
reflection of the degree of contamination
ofthe environment. After flushing airborne
pollutants from the skies, rainwater literally
washes over the entire human landscape
before running into the aquifers, streams,
rivers, and lakes that supply our drinking-
water. Any and all of the chemicals gener-
ated by human activity can and will find
their way into water supplies. Evaluating
possible links between drinking water
and cancer means identifying those chemi-
cals that appear in enough water supplies
at sufficient concentrations to pose a
substantial attributable cancer risk.
Contaminants may enter water supplies
at many points before reaching the tap. The
types and quantities of carcinogens present
in drinking water at the point of consump-
tion may result from contamination of the
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source water, arise as a consequence of
treatment processes, or enter as the water is
conveyed to the user. Many different car-
cinogens may contaminate source waters,
but they usually exist in drinking water at
low concentrations. On the other hand,
chemicals that enter drinking water during
the course ofwater treatment are limited in
number, but these chemicals appear in
drinking-water supplies with greater fre-
quency than most source water contami-
nants. Finally, the compounds contained in
the pipes, joints, and fixtures ofthe water
distribution system may contaminate
treated water on its way to the consumer.
Similarities in the construction ofdrinking-
water distribution systems mean that any
carcinogen entering through this pathway
may be widespread and can pose substantial
attributable risks of cancer. The following
discussion reviews the attributable risks
for contaminants entering at each ofthese
points. Data gaps are identified and
emerging areas ofconcern are discussed.
Source-Water Contaminants
Except for naturally occurring minerals
such as calcium carbonate, contaminants
that enter the water supply through the
source water generally occur at low con-
centration levels. Source-water contami-
nants of concern either are sufficiently
potent carcinogens to pose risks at
extremely low concentrations or cause
local contamination at high concentra-
tions. The source-water contaminants
that have been the focus of concern
among those individuals investigating
environmental cancer risks include arsenic,
asbestos, radon, agricultural chemicals,
and hazardous waste.
Some of the strongest evidence for a
cancer risk associated with source-water
contamination involves arsenic. Epidemi-
ologic studies from Taiwan have suggested
that arsenic in drinking water poses sub-
stantial risks of liver, lung, bladder, and
kidney cancer as listed in Table 1 (1,2).
Although toxicologic studies do not pro-
vide unequivocal evidence ofcarcinogenic-
ity (3), occupational studies, as well as
other epidemiologic studies, support the
findings of the Taiwanese studies(4).
Estimates ofattributable risk based on the
data in Table 1 suggest that an average
level of arsenic 2.5 pg/l in drinking water
in the United States of causes approxi-
mately 3000 cases ofcancer per year (4).
Although asbestos is a proven carcino-
gen, the attributable risks associated with
asbestos in drinking water do not appear to
be substantial. An early study in California
(5) suggested that there may be an
Table 1. Estimated mortality risk ratios by arsenic
levels in drinking water in Taiwan.
Cancer Back- Water levels, pg/l p-Value
site Sex ground 170 470 800 fortrend
Liver M 1.0 1.2 1.5 2.5 <0.001
F 1.0 1.6 2.1 3.6 <0.001
Lung M 1.0 1.8 3.3 4.5 <0.001
F 1.0 2.8 4.3 8.8 <0.001
Bladder M 1.0 5.1 12.1 28.7 <0.001
F 1.0 11.9 25.1 65.4 <0.001
Kidney M 1.0 4.9 11.9 19.6 <0.001
F 1.0 4.0 13.9 37.0 <0.001
Data from Chen et al. (1).
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elevation in colorectal cancer risk associ-
ated with asbestos in drinking water. It
appears that these findings are limited to
situations in which naturally occurring lev-
els are high. A subsequent, more detailed
study ofasbestos in source water, together
with studies ofasbestos leached from water
distribution systems, suggests that, when
asbestos is present at levels commonly
found in drinking water, it does not pose a
major cancer risk (6,7).
Radon is also a known carcinogen;
however, the evidence linking consumption
of radon-contaminated water to human
cancer is weak (8). The relationship
between ionizing radiation and cancer is
well understood. This information, coupled
with measured levels of radon in drinking
water, suggests that fewer than 100 cases of
cancer occur each year in the United States
as a consequence of consuming radon in
drinking water (9).
Farm runoff containing agricultural
chemicals and manure may lead to local or
regional contamination of source waters
with insecticides, fungicide, rodenticides,
herbicides, and fertilizers, which contain
phosphorous and nitrogen. Although some
pesticides are carcinogens, drinking-water
contamination resulting from their agricul-
tural application has not been directly asso-
ciated with cancer in epidemiologic studies.
Emerging evidence, however, indicates that
fertilizers maypose cancer risks.
Studies in China among populations
exposed to high levels of nitrates in drink-
ing water have suggested links between
nitrate contamination and stomach and
liver cancer (10). In these studies, the
histology of the gastric lesions has been
linked to the level of nitrates in the water
(11) and cancer rates increased with the in
vitro mutagenicity of the drinking water
(12). Nitrates may act as carcinogens
through the formation of N-nitroso com-
pounds (13). When human volunteers
were given proline, which is a secondary
amine, those participants in areas with
higher levels of nitrate in their drinking
water had higher levels ofN-nitrosoproline
in their urine than volunteers residing in
places with low nitrate levels in their drink-
ing water (14). Although an epidemiologi-
cal study in France failed to demonstrate
an association between nitrates in drinking
water and cancer (15), current evidence is
sufficient to warrant further study of this
potential carcinogen.
Few examples of significant links
between hazardous waste in drinking water
and cancer have been reported. Elevated
cancer risks are difficult to detect because
of the relatively low incidence of site-
specific neoplasms and the typically small
size ofexposed populations (16). An eco-
logic study in New Jersey found weak evi-
dence for a positive association between
volatile organic compounds in drinking
water and leukemia (17). In a national
ecologic study, Griffith et al. (18) found
evidence of elevated cancer rates in the
vicinity ofhazardous waste sites. Limita-
tions on ecologic data urge caution in the
interpretation ofsuch findings. Contami-
nation ofwells associated with hazardous
waste disposal in Woburn, Massachusetts,
was ultimately linked to elevations in their
incidence of leukemia (19). Although this
investigation was arguably the most thor-
ough study of this kind, questions were
raised about the magnitude of the risk
(20). There are numerous factors that
make it difficult, ifnot impossible, to esti-
mate the attributable risks associated with
hazardous wastes on a national level,
including the wide variety of chemicals
present in hazardous waste sites, the
difficulties in assessing exposure, the obsta-
cles to establishing links between exposure
and cancer even when links are present, the
small size ofexposed populations, and the
uncertainties concerning future risks.
Cancer Risks Associated
with Water Treatment
Until this century, concerns about the
cleanliness of drinking water focused
almost exclusively on the presence or
absence ofpathogens. Ironically, the chlo-
rine used to reduce the risk of infectious
disease may account for a substantial por-
tion of the cancer risk associated with
drinking water.
Chlorination ofdrinking water played a
central role in the reduction in the mortal-
ity rates associated with waterborne
pathogens. Water chlorination was first
introduced at the Jersey City Water Works
in Boonton, New Jersey. The relative ease
of use ofwater chlorination, together with
its potent bactericidal action, lead to the
rapid dissemination ofthis treatment tech-
nology throughout the United States.
Overshadowed by the clear benefits to
public health, the potential health risks
associated with water chlorination received
little attention. This view is evident in an
article heralding the opening of the
Boonton waterworks, which appeared on
the back page ofthe New York Times (21).
The brief article claimed that, with this
process, "any municipal water supply can
be made as pure as mountain spring water.
Chlorination destroys all animal and
microbial life, leaving no trace of itself
afterwards" (21).
This statement represented the prevail-
ing wisdom until about 20 years ago when
halogenated organic compounds, particu-
larly chloroform, were identified in chlori-
nated drinking water (22). A subsequent
survey ofwater supplies showed that these
compounds were common in water sup-
plies throughout the United States and that
concentrations were far higher in treated
surface water than in treated groundwater
(23). With these revelations came a shift in
the basis ofour definition ofcleanliness in
drinking water. New concerns about cancer
risks associated with chemical contamina-
tion from chlorination by-products have
given rise to 25 epidemiologic studies.
Table 2 summarizes the results of a
metaanalysis ofthe cohort and case-control
studies that have been conducted to evalu-
ate the association between consumption
ofchlorinated drinking water and cancer at
various sites (24). For each cancer site, the
pooled results from available studies show
elevations in risk, and the risk estimates
achieved statistical significance for bladder
and rectal cancer. Further analyses in this
study suggested that risks increased with
increasing exposure and that improvements
in exposure assessment yielded higher
estimates ofrisk. Confounding could con-
ceivably explain the observed pattern of
association, but stratification into studies
that adjusted or did not adjust for con-
founders does not support such an asser-
tion. Studies that adjusted for population
density, smoking, or occupation, did not
demonstrate a difference in relative risk
estimates. Although it is still possible that
the pattern of associations could represent
Table 2. Results from metaanalysis of chlorination
by-products and cancer.
Relative risk 95% Confidence
Site n8 estimate interval p
Bladder 7 1.21 1.09 1.34 <0.0001
Brain 2 1.29 0.53 3.14 0.56
Breast 4 1.18 0.90 1.54 0.24
Colon 7 1.11 0.91 1.35 0.32
Colorectal 8 1.15 0.97 1.37 0.10
Esophagus 5 1.11 0.85 1.45 0.43
Kidney 4 1.16 0.89 1.51 0.23
Liver 4 1.15 0.94 1.40 0.16
Lung 5 1.01 0.86 1.18 0.94
Pancreas 6 1.05 0.91 1.22 0.48
Rectum 6 1.38 1.01 1.87 0.04
Stomach 6 1.14 0.94 1.38 0.19
'Number of studies evaluating specific cancer site.
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some systematic bias in the available studies,
no specific bias has emerged to explain the
observed results.
In summary, the available studies gen-
erally support the notion that by-products
of chlorination are associated with
increased cancer risks. The precise charac-
terization of these risks is somewhat less
clear. The broad category of chlorination
by-products includes many different com-
pounds, and the carcinogens among these
compounds have not been clearly identi-
fied. Trihalomethanes are the most preva-
lent compounds and, given the evidence
suggesting that they are animal carcino-
gens, have been the focus of research and
regulation. The chlorination by-products
that have been specifically identified, how-
ever, account for only about half of the
bound chlorine in finished drinking water.
Other compounds present in far smaller
quantities may pose substantial cancer risks
byvirtue ofhigh potency (25).
The goal of precise characterization of
the cancer risk posed by each ofthe chlori-
nation by-products will probably prove to
be unrealistic. A quantitative dose-response
relationship has not been well described for
any individual compound, much less the
entire complex mixture. The relative con-
tributions of different exposure pathways
vary among the by-products and have not
been well characterized. Nonetheless, given
the large number ofpeople who consume
chlorinated surface water, the number of
cases of cancer potentially attributable to
this exposure is substantial. The numbers
derived from the metaanalysis suggest that
5000 (95% CI =2000-7000) cases ofblad-
der cancer per year and 8000 cases ofrectal
cancer per year (95% CI = 200-14,000)
may be associated with consumption of
chlorinated drinking water. Although these
figures do not provide a precise estimate of
risk, the true risk is probably within an
order ofmagnitude ofthese values.
Since the publication of the meta-
analysis, a number of other studies have
been completed. McGeehin et al. (26)
found an elevated risk for bladder cancer
comparable in magnitude to the summary
estimate of the metaanalysis. Kuovaslo et
al. (27) found a similar estimate ofrisk for
bladder cancer but did not find an elevated
risk for rectal cancer. Kantor (28), on the
other hand, found a risk for rectal cancer
similar to that in the metaanalysis, but an
increase in bladder cancer risk associated
with chlorination by-products was only
observed among smokers. Including these
findings within the metaanalysis does not
change its results. Nonetheless, these
apparent inconsistencies may reflect impor-
tant differences in the carcinogenicity of
the exposures experienced among the
various study populations. The complex
mixture ofcompounds that comprise chlo-
rination by-products, the multiple path-
ways ofexposure to those compounds, and
the potential for synergy with diet and
other exposures maywell explain the appar-
ent inconsistencies that exist among the
studies included in the metaanalysis.
To stop chlorination ofdrinking-water
to eliminate the elevated cancer risks from
chlorination by-products would be fool-
hardy. Nonetheless, the data provide strong
evidence to support expanded efforts in
research and development ofalternatives to
chlorination for the disinfection ofdrink-
ing-water. Chlorination is particularly effec-
tive in preventing recontamination during
distribution. Alternatives must provide a
similar level ofprotection. The capacity of
chemical disinfectants to kill pathogens gen-
erally reflects their strong tendency to react
with organic chemicals. The production of
by-products may, therefore, be inherent to
the chemical disinfection ofdrinking water.
For example, ozone produces aldehydes
including formaldehyde and bromate if
the source waters contain bromine. These
compounds pose a cancer risk that is not
yet fully quantified (29). Before the wide-
spread introduction ofany new method of
water treatment, the carcinogenicity of
by-products should be carefully evaluated.
Of the other compounds routinely
added during the course ofdrinking-water
treatment, fluoride has received the greatest
scrutiny as a potential carcinogen. The
International Agency for Research on
Cancer ([ARC) Working Group on Cancer
Risks from Fluoridated Drinking Water has
concluded that available ecologic studies
have been consistent in finding no risk but
stopped short ofsuggesting that flouride
was not carcinogenic because the studies
were all ecologic in design (30). One ani-
mal study (31) and one case-control study
(32) suggested that fluoridated water could
be linked with osteosarcoma, but these
findings will require further confirmation
to be considered suggestive ofcausality. It
appears that if flouride poses any cancer
risk, the attributable risk is relatively small.
Cancer Risks Associated with
Drinking-Water Distribution
The chemical components ofpipes, joints,
and fixtures can contaminate drinking
water after treatment. A broad range of
materials are used in these systems. Pipes
can be made from metals, primarily iron,
copper and lead; plastics, such as polyvinyl
chloride and polyethylene; and concrete or
asbestos/concrete aggregates. These pipes
may be plated or lined with a variety of
compounds including zinc, coal tar,
asphalt, or vinyl. In addition, bacteria and
organic matter frequently coat the inside of
pipes within the distribution systems (33).
All ofthese can be sources ofnew contami-
nation, or they can combine with chemicals
already in the water to alter the health risks
posed by drinking water. In 1979, a study
of several medium-size water systems
demonstrated increases in mutagenicity of
drinking water after passage through the
distribution system (34). This study did
not isolate specific contaminants that might
be responsible. Perhaps the most extensively
studied contaminant associated with drink-
ingwater distribution is asbestos, which can
leach from asbestos-concrete pipes. The
available research suggests that asbestos
from this source does not pose significant
human cancer risks (35-37). A study by
Ashengrau et al. (38) showed an increase in
leukemia in association with trichlorethyl-
ene, which had leached from a plastic liner
used in concrete pipes. Other than the
negative results ofthe asbestos studies, the
available research does not allow for strong
conclusions concerning the magnitude of
cancer risks relating to contamination from
the distribution system. Further research is
needed to identify and quantify risks posed
by contamination that occurs during
drinking-water distribution.
Emerging Concerns and
Potential Cancer Risks
Water is among the most basic require-
ments for human survival, therefore,
emerging health threats related to drinking-
water contamination demand careful con-
sideration. Although the identification of
potential threats to human health requires a
certain degree ofspeculation, protection of
public health requires a willingness to occa-
sionally err in the name ofcaution. Cancer
risks may emerge from the micropollutants
and microbial contaminants that can enter
our drinking-water supply. Less direct
effects may also pose risks.
One focus of current concerns about
the potential for micropollutants to cause
cancer involves those compounds that
mimic naturally occurring, biologically
active compounds. Biologically active
micropollutants or endocrine disrupters
appear to have the ability to disturb normal
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intercellular communications. For example,
evidence from wildlife biologists, toxi-
cologists, endocrinologists, and epidemiol-
ogists demonstrate the potential for
estrogenic effects ofenvironmental conta-
minants among humans (39,40). Meta-
bolites of DDT are estrogenic in vivo and
have been associated with the development
of breast cancer in epidemiologic studies
(41,42). Nonyl-phenol, a common chemi-
cal surfactant, increases proliferation in
breast tumor cell cultures (43). The poten-
tial risks from drinking-water contami-
nants acting through these mechanisms
have not been evaluated.
Because ofthe complex mixture ofcon-
taminants, examining cancer risks for each
individual compound may not give a com-
plete picture ofcancer risks associated with
drinking water. An alternative approach is
to look at the geographic distribution of
neoplasms that might be associated with
drinking water. These include cancer ofthe
gastrointestinal tract and bladder cancer
(i.e., neoplasms of the mucosal epithe-
lium). Figure 1 provides maps showing
clustering of the incidence ofsite-specific
neoplasms among the elderly. By ranking
the incidence of the neoplasms of the
mucosal epithelium and combining those
ranks, we can see where this group ofneo-
plasms might be elevated. A map of the
clustering ofelevated cancer rates is shown
in Figure 2. This map indicates a
significant elevation ofthese cancers in the
northeastern United States. To draw con-
clusions about the link between the geo-
graphic distribution and drinking water
would, of course, be premature, but any
effort to explain this pattern should con-
sider drinking-water contamination to be a
possible contributing factor.
Microbial contaminants also have
carcinogenic potential. For example,
Schistosoma haematobium is waterborne,
although it is not transmitted by drinking-
water, and has been linked to cancer ofthe
urinary bladder (44). Tumor promotion by
algal toxins has already been suggested in
literature (45). Bacteria, parasites, and
viruses appear sporadically in most water
supplies. The possibility that currently
unidentified pathogens in drinking water
can cause cancer should not be overlooked.
Water pollution may pose cancer risks
other than the direct, toxic effects ofexpo-
sure to contaminated water. Causal links
for the effects described below have not
been clearly established, but they are plau-
sible and should be considered in evaluating
cancer risks from drinking water.
- -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.-
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Figure 1. Rank sum map of incidence rates among persons 65 and older for cancers of the esophagus, stomach,
colon, rectum, and bladderfrom 1988to 1989 (based on Appendix I).
,-- ----Notsignificant miSignificance and ratec med _ Significance and rate >med
Figure 2. Areas of significant clustering of elevated rates of mucosal neoplasms. Significance of Moran's l:
p<O.OOOl
Contamination offishing grounds may
pose both direct and indirect cancer risks.
Persistent, potentially carcinogenic com-
pounds, such as polychlorinated biphenyls,
accumulate in the fatty tissues offish (46).
Fish consumption is a major exposure
pathway for these compounds. In addition,
contamination or destruction ofspawning
grounds may combine with over-fishing to
deplete natural fisheries. A dietary shift
from fish to red meat, either because of
diminished fish stocks or fear of contami-
nants, could also increase diet-associated
cancer risks.
Under conditions ofaverage tempera-
ture, humidity, and activity, the human
bodyloses and, therefore, must replace about
2.3 liters ofwater each day. Two-thirds of
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this consumption is in the form ofwater or
some other beverage. Concerns about the
health risks or taste of drinking water may
induce those who consume tap water to
shift to bottled water, or other beverages.
These beverages may include sweetened soft
drinks and alcoholic beverages, which can
pose health risks greater than those associ-
ated with drinking water. In addition, the
production and disposal ofcontainers for
alternative beverages, including bottled
water, maylead to the release ofcarcinogens.
Summary and Prevention
Strategies
The cancer risks associated with the major
contaminants of drinking water are listed
in Table 3. The weight of the evidence
suggests that chlorination by-products pose
substantial cancer risks that should be
reduced. A growing body ofevidence sup-
ports the possibility that arsenic in drink-
ing water may also carry unacceptable
cancer risks. The cancer risks from radon
and asbestos in drinking water are less sub-
stantial but may require remediation where
local conditions dictate. The available
evidence does not support assertions of
cancer risks associated with fluoridation of
drinking water.
For most other compounds present in
drinking water, the attributable cancer
risks are not clear. Hazardous waste and
pesticides may contaminate waters locally
and regionally, but the attributable cancer
risk is difficult to quantify. Nitrates are
more widespread contaminants and more
closely linked to human cancer, but evi-
dence is incomplete. Contamination dur-
ing drinking-water distribution may pose
cancer risks, but the epidemiologic
evidence is extremely limited. Less conven-
tional cancer risk factors, such as biologi-
cally active micro pollutants and pathogens,
only present the possibility of risk at
present but may emerge as important
carcinogens in the future.
Cancer-prevention strategies must focus
on source-water purity. In particular,
strong source-water protection efforts pro-
vide a barrier to emerging cancer risks that
have not been identified or fully character-
ized. Furthermore, failure to protect source
water purity will necessitate more extensive
water treatment and, in most cases, heavier
chlorination. Drinking-water treatment
technologies should be evaluated with
extreme care and should be reevaluated on
a regular basis. The concept ofcontinuous
quality improvement should be fully inte-
grated into drinking-water treatment and
should include ongoing efforts to develop,
evaluate, and implement new treatment
technologies. More cost-effective methods
Table 3. Carcinogenic risk associated with major
contaminants of drinking water.
Attributable risk Contaminant Point of Entry
Substantial Chlorination Treatment
by-products
Arsenic Source water
Small to Asbestos Source water,
moderate distribution
Radionuclides Source water
Little or none Fluoride Treatment
Unknown Hazardous waste Source water
Pesticides Source water
Tetrachloroethylene Distribution
Nitrates Source water
Pathogens Source water,
distribution
Biologically active Source water,
micropollutants distribution (?)
for monitoring drinking-water quality need
to be aggressively developed. Finally,
drinking-water research should be a prior-
ity. The consequences ofa lack ofvigilance
with respect to emerging threats in drink-
ing water were felt with devastating impact
in Milwaukee, Wisconsin, in 1993, when
400,000 people fell ill during a waterborne
outbreak of cryptosporidiosis (47). We
should view this as a warning and an
opportunity for timely intervention to
minimize health risks from drinkingwater.
Appendix I
The map of cancer incidence rates for
mucosal cancer was based on the applica-
tion ofthe method described below.
Assessing CancerIncidence Rates
The incidence of cancer of the esophagus,
stomach, colon, and urinary bladder for
persons over 64 years ofage for the period
1988 through 1989 was estimated using
Medicare hospital admissions data. The
method used to estimate cancer incidence
with this database is reported elsewhere
(1-3). Briefly stated, all patients with a hos-
pital admission for cancer were identified.
Patients with no admissions for the site
specific cancer diagnosis in the previous 4
years were considered to represent incident
cases. From these, age and sex adjusted,
race-specific cancer rates were determined.
LocalizingDiseawe Clusters
A disease cluster can be defined as a group
of geographic areas that are close to one
another with disease rates that are simi-
larly increased or decreased relative to
surrounding areas. This can be expressed
quantitatively for each analytic area i, as the
weighted covariance of its disease rate (xi)
with the rates for the rest of the analytic
areas in the study region (xj) as given by
wij(xi-X-)(xj-X-) [1]
n-1
where the weights (w,1) are the inverse of
the distance between population centroids
ofthe analytic areas (4).
If the sizes of the study areas are not
homogeneous across the study regions,
the weights corresponding to two adjacent
areas will vary according to the size of
those areas. After modification to accom-
modate variations in region size, the
regional spatial autocorrelation coefficient
(RSAC) for analytic area i, Ri, becomes
E(xi )2x(wii )
Ri =(xi- -E _2(Wi_)
The mean and standard deviation of the
distribution of RSAC can be reasonably
approximated by a normal distribution
with an expectation ofzero and a standard
deviation ofa/(n-2)1/2 where a is the stan-
dard deviation ofxiand n is the number of
analytic areas.
The RSAC was calculated for each ana-
lytic area, and the theoretical mean and
standard deviation were used to test for
significance. Analytic areas that have
significantly high RSACs were further
classified into two groups based on
whether their disease rates were greater or
less than the median rate. Analytic areas
with significant RSACs and disease rates
greater than the median were defined as
analytic areas with clustering of elevated
disease rates or high clusters. These ana-
lytic areas were shaded black in the map.
Analytic areas with significant RSACs and
disease rates less than the median were
defined as analytic areas with clustering of
low disease rates or low clusters. When
the value ofthe RSAC was not significant,
analytic areas were not shaded and
Volume 103, Supplement8, November 1995 229R.D. MORRIS
A B~~~~~~~~~~~~~~~~~~~~~~~
C D
Notsignificant _ Significance and rate < med Significance and rate > med
Figure Al. Regional spatial autocorrelation coefficient (RSAC) maps showing localized areas containing statistically significant disease clusters. (A) Malignant neoplasm of
the esophagus. (B) Malignant neoplasm ofthe bladder. (C) Malignant neoplasm ofthe colon. (D) Malignant neoplasm ofthe stomach. Significance of Moran's l: p<O.OOOl.
represented random spatial structures.
Maps depicting the results of these analy-
ses (RSAC maps) were created to evaluate
the use of this method as a visual aid to
localize areas that contain disease clusters.
These methods are described in detail else-
where (1,4). The resulting maps are
shown in Figure Al.
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